Health Care: Drugs

Ophthotech Corp (OPHT: NASDAQ)

$47 -0.47 | -0.99%
12/19/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 47.38
52 Week High 50.00
52 Week Low 28.60
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 1,594.39
Shares Out (Mil) 33.65
Float (Mil) 13.87
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 19.10
Current Ratio 19.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 3.20
Price/Sales 40.29
Price/Book 9.06
Price/Cash Flow -19.60
Per Share Data
Earnings 14.97
Sales 1.18
Book Value 5.23
Cash Flow -2.42
Business Summary
Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration.
General Information
One Penn Plaza, 35th Floor
New York, NY 10119
www.ophthotechinc.com
Industry : Drugs
Sector: Health Care
Employees: 38
CEO: Dr. David R. Guyer,M.D.
Short Interest
Current Month (Mil) 1.88
Previous Month (Mil) 2.36
Short Interest Ratio (Days) 7.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -16.90
Return on Investments -47.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OPHT

Latest OPHT Headlines from TheStreet

More Financial News for OPHT

Press Releases for OPHT

See All Press Releases

Partner Headlines for OPHT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter